Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Constitutive activation of signal transducer and activator of transcription 3 (Stat3) has been found in a wide spectrum of human malignancies. Here, we have assessed the effect of Stat3 deficiency on skin tumor development using the 2-stage chemical carcinogenesis model. The epidermis of Stat3-deficient mice showed a significantly reduced proliferative response following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) because of a defect in G1-to-S-phase cell cycle progression. Treatment with the tumor initiator 7,12-dimethylbenz[a]anthracene (DMBA) resulted in a significant increase in the number of keratinocyte stem cells undergoing apoptosis in the bulge region of hair follicles of Stat3-deficient mice compared with nontransgenic littermates. Notably, Stat3-deficient mice were completely resistant to skin tumor development when DMBA was used as the initiator and TPA as the promoter. Abrogation of Stat3 function using a decoy oligonucleotide inhibited the growth of initiated keratinocytes possessing an activated Ha-ras gene, both in vitro and in vivo. In addition, injection of Stat3 decoy into skin tumors inhibited their growth. To our knowledge, these data provide the first evidence that Stat3 is required for de novo epithelial carcinogenesis, through maintaining the survival of DNA-damaged stem cells and through mediating and maintaining the proliferation necessary for clonal expansion of initiated cells during tumor promotion. Collectively, these data suggest that, in addition to its emerging role as a target for cancer therapy, Stat3 may also be a target for cancer prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Cotsarelis, G., Sun, T.-T., & Lavker, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90696-c · Cited by 2,276
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“First, targeting of Stat3 as an anticancer therapy is clearly an important goal (50); in addition, targeting of Stat3 together with DNA-damaging chemotherapies may specifically sensitize cancer cells to apoptosis.”
BackgroundInvolvement of Follicular Stem Cells in Forming Not Only the Follicle but Also the Epidermis
Taylor, G., Lehrer, M. S., Jensen, P. J., Sun, T.-T., & Lavker, R. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00050-7 · Cited by 1,070 · cited 2×
“org Volume 114 Number 5 September 2004 723 Evidence has accumulated suggesting that keratinocyte stem cells reside primarily in the bulge region of the hair follicle, where they are physically protected by the epidermis (18, 19).”
BackgroundOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 949
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 770
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Multistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Self-citationEpling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633 · cited 2×
“It is known that several antiapoptotic molecules such as Bcl-xL (46), Bcl-2 (47), and Mcl-1 (48) are downstream targets for Stat3.”
BackgroundMora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 603
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Self-citationGrandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502
Identification of CDK4 as a target of c-MYC
Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W., Kohlhuber, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050586197 · Cited by 471
Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin
Ghazizadeh, S., & Taichman, L. B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1215 · Cited by 348
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0534764100 · Cited by 340
Rescue of Cyclin D1 Deficiency by Knockin Cyclin E
Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Sicinski, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336
Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27Kip1 and p21Cip1
Perez-Roger, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5310 · Cited by 329
Stem-cell hierarchy in skin cancer
Perez-Losada, J., & Balmain, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1095 · Cited by 268
Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 255
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
Regulation of Bcl-xL: a little bit of this and a little bit of STAT
Grad, J. M., Zeng, X.-R., & Boise, L. H. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00006 · Cited by 231
Ernst, M., Inglese, M., Waring, P., Campbell, I. K., Bao, S., Clay, F. J., Alexander, W. S., Wicks, I. P., Tarlinton, D. M., Novak, U., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.189 · Cited by 227 · cited 1×
“In other studies, Erk-MAPK and Stat3 have been shown to have a reciprocal relationship in mediating proliferation (31).”
BackgroundRobles, A. I., Rodriguez-Puebla, M. L., Glick, A. B., Trempus, C., Hansen, L., Sicinski, P., Tennant, R. W., Weinberg, R. A., Yuspa, S. H., & Conti, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.16.2469 · Cited by 217
Nielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Connections between growth and the cell cycle
Neufeld, T. P., & Edgar, B. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80122-1 · Cited by 183
Keratinocyte Stem Cells: a Commentary1
Potten, C. S., & Booth, C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00020.x · Cited by 180
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck
Xi, S., Zhang, Q., Dyer, K. F., Lerner, E. C., Smithgall, T. E., Gooding, W. E., Kamens, J., & Grandis, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303499200 · Cited by 180
Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein
Ichiba, M., Nakajima, K., Yamanaka, Y., Kiuchi, N., & Hirano, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6132 · Cited by 175 · cited 1×
“A previous report has shown that Stat3 can regulate its own transcription (22).”
BackgroundHennings, H., Glick, A. B., Lowry, D. T., Krsmanovic, L. S., Sly, L. M., & Yuspa, S. H. (1993) · Carcinogenesis · doi:10.1093/carcin/14.11.2353 · Cited by 169
The role of RB in cell cycle control
Hatakeyama, M., & Weinberg, R. A. (1995) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-1809-9_2 · Cited by 164
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
Self-citationEvidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen.
Morris, R. J., Fischer, S. M., & Slaga, T. J. (1986) · PubMed · Cited by 132
Berns, K., Hijmans, E. M., & Bernards, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201280 · Cited by 115
Pestell, R. G., Albanese, C., Watanabe, G., Johnson, J., Eklund, N., Lastowiecki, P., & Jameson, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18301 · Cited by 109
Keratinocyte stem cells: targets for cutaneous carcinogens
Morris, R. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10508 · Cited by 109
Morris, R. J., Tryson, K. A., & Wu, K. Q. (2000) · PubMed · Cited by 108
Dlugosz, A. A., Hansen, L. A., Cheng, C., Alexander, N., Denning, M. F., Threadgill, D. W., Magnuson, T., Coffey, R. J., & Yuspa, S. H. (1997) · PubMed · Cited by 80
A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.
Pena, J. C., Rudin, C. M., & Thompson, C. B. (1998) · PubMed · Cited by 71
Dlugosz, A. A., Cheng, C., Williams, E. K., Darwiche, N., Dempsey, P. J., Mann, G. B., Dunn, A. R., Coffey, R. J., & Yuspa, S. H. (1995) · PubMed · Cited by 68
Matsumoto, T., Jiang, J., Kiguchi, K., Ruffino, L., Carbajal, S., Beltrán, L., Bol, D. K., Rosenberg, M. P., & DiGiovanni, J. (2003) · PubMed · Cited by 67
Self-citationSchorl, C., & Sedivy, J. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0649 · Cited by 51
Umeda, J., Sano, S., Kogawa, K., Motoyama, N., Yoshikawa, K., Itami, S., Kondoh, G., Watanabe, T., & Takeda, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0597com · Cited by 49
Self-citationRodríguez‐Puebla, M. L., Robles, A. I., Johnson, D. G., LaCava, M., & Conti, C. J. (1998) · PubMed · Cited by 44
Cited by
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., et al. (2012) · Nature · doi:10.1038/nature10831 · Cited by 1,523
“For example, STAT3 was found to be crucial in initiation and progression of skin carcinoma (34), and the growth and survival of lymphomas are dependent on STAT3 (35).”
BackgroundNF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Metadata
- Authors
- Chan, K. S., Sano, S., Kiguchi, K., Anders, J., Komazawa, N., Takeda, J., & DiGiovanni, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-09-01
- Volume
- 114
- Issue
- 5
- Pages
- 720-728
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1994562522
- Cited by
- 356
- References
- 52
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.